Bruton's tyrosine kinase (BTK) drugs for Multiple Sclerosis

3 tracked Bruton's tyrosine kinase (BTK) drugs in the Multiple Sclerosis race. The class explanation lives on the Bruton's tyrosine kinase (BTK) page; the full indication pipeline across every mechanism is on the Multiple Sclerosis page.

2 Phase 31 Phase 2

Head-to-head evidence: Corubrutinib vs Tolebrutinib · Corubrutinib vs remibrutinib · remibrutinib vs Tolebrutinib

The roster

← all Bruton's tyrosine kinase (BTK) drugs